Laura Palmieri

2PUBLICATIONS
14CO-AUTHORS
Gene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

Sort by Publication Date:
|Oct 22, 2025
Lysosomal damage is a therapeutic target in Duchenne muscular dystrophy.

Abbass Jaber, Laura Palmieri, Rania Bakour

|Oct 16, 2024
In Silico Structural Prediction for the Generation of Novel Performant Midi-Dystrophins Based on Intein-Mediated Dual AAV Approach.

Laura Palmieri, Maxime Ferrand, Ai Vu Hong

Pageof 1

Frequent Collaborators

2 joint publications

Ai Vu Hong

2 joint publications

Isabelle Richard

2 joint publications

Sonia Albini

1 joint publications

Abbass Jaber

1 joint publications

Nathalie Bourg

1 joint publications

Elise Lachiver

1 joint publications

Carinne Roudaut

1 joint publications

Daniel Stockholm

1 joint publications

Guillaume Tanniou

1 joint publications

Nathalie Danièle

Frequent Collaborators

2 joint publications

Ai Vu Hong

2 joint publications

Isabelle Richard

2 joint publications

Sonia Albini

1 joint publications

Abbass Jaber

JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us

Top Related Videos

CRISPR/Cas9 Technology in Restoring Dystrophin Expression in iPSC-Derived Muscle Progenitors
07:44

CRISPR/Cas9 Technology in Restoring Dystrophin Expression in iPSC-Derived Muscle Progenitors

Published on : Sep 14, 2019

8.8K
Direct Reprogramming of Human Fibroblasts into Myoblasts to Investigate Therapies for Neuromuscular Disorders
10:28

Direct Reprogramming of Human Fibroblasts into Myoblasts to Investigate Therapies for Neuromuscular Disorders

Published on : Apr 03, 2021

6.2K
See more related videos

Top Related Videos

CRISPR/Cas9 Technology in Restoring Dystrophin Expression in iPSC-Derived Muscle Progenitors
07:44

CRISPR/Cas9 Technology in Restoring Dystrophin Expression in iPSC-Derived Muscle Progenitors

Published on : Sep 14, 2019

8.8K
Direct Reprogramming of Human Fibroblasts into Myoblasts to Investigate Therapies for Neuromuscular Disorders
10:28

Direct Reprogramming of Human Fibroblasts into Myoblasts to Investigate Therapies for Neuromuscular Disorders

Published on : Apr 03, 2021

6.2K
See more related videos